1 – 10 of 37
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2024
- 
                        Mark
        Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants
    
    - Contribution to journal › Article
 
- 
                        Mark
        Molecular patterns of resistance to immune checkpoint blockade in melanoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        BioMEL : a translational research biobank of melanocytic lesions and melanoma
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Transcriptomic signatures of tumors undergoing T cell attack
    
    - Contribution to journal › Article
 
- 
                        Mark
        DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
    
    - Contribution to journal › Article
 
- 
                        Mark
        Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
    
    - Contribution to journal › Article
 
- 2020
- 
                        Mark
        Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8+ T cells in non-melanoma cancers compared to melanoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Tertiary lymphoid structures improve immunotherapy and survival in melanoma
    
    - Contribution to journal › Article
 
